Antiviral nucleosides
Details for Australian Patent Application No. 2006324098 (hide)
International Classifications
Event Publications
3 July 2008 PCT application entered the National Phase
PCT publication WO2007/065829 Priority application(s): WO2007/065829
24 February 2011 Application Accepted
Published as AU-B-2006324098
23 June 2011 Standard Patent Sealed
28 July 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 29 Jun 2011. Address for service in Australia - Wrays 56 Ord Street West Perth WA 6005
8 December 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 29 Jun 2011
17 May 2012 Alteration of Name
The name of the patentee has been altered to F. Hoffmann-La Roche AG; Gilead Pharmasset LLC
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006324121-Method for interconnecting electric cables
2006324097-Glucocorticoid receptor modulators as antiinflammatory agents
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser